Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT01390220
Status:
TERMINATED
Last Update Posted:
2019-10-10
First Post:
2011-07-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
Sponsor:
UCB Biopharma S.P.R.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-06
First Submit QC Date:
None
Study First Post Date:
2011-07-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-09
Results First Submit QC Date:
None
Results First Post Date:
2019-05-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-03-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2019-10-08
Last Update Post Date:
2019-10-10
Last Update Post Date Type:
ACTUAL